Cite

HARVARD Citation

    Houédé, N. et al. (2014). A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration‐Resistant Prostate Cancer. Oncologist. pp. 1227-1228. [Online]. 
  
Back to record